NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
This open tender from NHS England was published in 2026. The NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide contract with a submission deadline of 9 March 2026.
This UK government contract opportunity is part of the public procurement process, openly available via Find a Tender.
Ask the AI assistant for deeper analysis of this scope
Important deadlines and milestones
Tender opportunity made public on Find a Tender
Final deadline for bid submission
This is a public procurement by NHS England. All UK government contracts are publicly accessible for transparency.
This NHS England tender is open for bids. Deadline: 09/03/2026. Submit your proposal via Find a Tender.
Analyze how well this tender matches your company profile and capabilities.
ocds-h6vhtk-051c39RFP.quest helps UK businesses find and win public sector tenders. Our AI platform analyzes requirements, identifies gaps, and helps craft winning proposals.
AI-powered bid management
UK procurement tools
Expert guidance
Step-by-step guide
UK tender data from Find a Tender under the Open Government Licence. Powered by RFP.quest.
I can help you understand this NHS England contract:
• Requirements and evaluation criteria • Risks and gaps analysis • Buyer and market context • Related opportunities
Ask me anything about "NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide"!
Powered by CopilotKit